Global Rifaximin Market 2020 by Manufacturers, Countries, Type and Application, Forecast to 2025

  • receipt Report ID : 7797
  • calendar_today Published On: Feb, 2020
  • file_copy Pages: 101
  • list Pharmaceuticals and Healthcare
Buy @ $3480
Rifaximin, sold under the trade name Xifaxan among others, is an antibiotic used to treat traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy. It has poor absorption when taken by mouth.

Scope of the Report:
The global Rifaximin market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Rifaximin.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Rifaximin market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Rifaximin market by product type and applications/end industries.

Market Segment by Companies, this report covers
Salix Pharmaceuticals

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
200 mg Tablets
550 mg Tablets

Market Segment by Applications, can be divided into
Hospital
Drug store
Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents
1 Rifaximin Market Overview
1.1 Product Overview and Scope of Rifaximin
1.2 Classification of Rifaximin by Types
1.2.1 Global Rifaximin Revenue Comparison by Types (2019-2024)
1.2.2 Global Rifaximin Revenue Market Share by Types in 2018
1.2.3 200 mg Tablets
1.2.4 550 mg Tablets
1.3 Global Rifaximin Market by Application
1.3.1 Global Rifaximin Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Rifaximin Market by Regions
1.4.1 Global Rifaximin Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Rifaximin Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Rifaximin Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Rifaximin Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Rifaximin Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Rifaximin Status and Prospect (2014-2024)
1.5 Global Market Size of Rifaximin (2014-2024)
2 Manufacturers Profiles
2.1 Salix Pharmaceuticals
2.1.1 Business Overview
2.1.2 Rifaximin Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Salix Pharmaceuticals Rifaximin Revenue, Gross Margin and Market Share (2017-2018)
3 Global Rifaximin Market Competition, by Players
3.1 Global Rifaximin Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Rifaximin Players Market Share
3.2.2 Top 10 Rifaximin Players Market Share
3.3 Market Competition Trend
4 Global Rifaximin Market Size by Regions
4.1 Global Rifaximin Revenue and Market Share by Regions
4.2 North America Rifaximin Revenue and Growth Rate (2014-2019)
4.3 Europe Rifaximin Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Rifaximin Revenue and Growth Rate (2014-2019)
4.5 South America Rifaximin Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Rifaximin Revenue and Growth Rate (2014-2019)
5 North America Rifaximin Revenue by Countries
5.1 North America Rifaximin Revenue by Countries (2014-2019)
5.2 USA Rifaximin Revenue and Growth Rate (2014-2019)
5.3 Canada Rifaximin Revenue and Growth Rate (2014-2019)
5.4 Mexico Rifaximin Revenue and Growth Rate (2014-2019)
6 Europe Rifaximin Revenue by Countries
6.1 Europe Rifaximin Revenue by Countries (2014-2019)
6.2 Germany Rifaximin Revenue and Growth Rate (2014-2019)
6.3 UK Rifaximin Revenue and Growth Rate (2014-2019)
6.4 France Rifaximin Revenue and Growth Rate (2014-2019)
6.5 Russia Rifaximin Revenue and Growth Rate (2014-2019)
6.6 Italy Rifaximin Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Rifaximin Revenue by Countries
7.1 Asia-Pacific Rifaximin Revenue by Countries (2014-2019)
7.2 China Rifaximin Revenue and Growth Rate (2014-2019)
7.3 Japan Rifaximin Revenue and Growth Rate (2014-2019)
7.4 Korea Rifaximin Revenue and Growth Rate (2014-2019)
7.5 India Rifaximin Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Rifaximin Revenue and Growth Rate (2014-2019)
8 South America Rifaximin Revenue by Countries
8.1 South America Rifaximin Revenue by Countries (2014-2019)
8.2 Brazil Rifaximin Revenue and Growth Rate (2014-2019)
8.3 Argentina Rifaximin Revenue and Growth Rate (2014-2019)
8.4 Colombia Rifaximin Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Rifaximin by Countries
9.1 Middle East and Africa Rifaximin Revenue by Countries (2014-2019)
9.2 Saudi Arabia Rifaximin Revenue and Growth Rate (2014-2019)
9.3 UAE Rifaximin Revenue and Growth Rate (2014-2019)
9.4 Egypt Rifaximin Revenue and Growth Rate (2014-2019)
9.5 Nigeria Rifaximin Revenue and Growth Rate (2014-2019)
9.6 South Africa Rifaximin Revenue and Growth Rate (2014-2019)
10 Global Rifaximin Market Segment by Type
10.1 Global Rifaximin Revenue and Market Share by Type (2014-2019)
10.2 Global Rifaximin Market Forecast by Type (2019-2024)
10.3 200 mg Tablets Revenue Growth Rate (2014-2024)
10.4 550 mg Tablets Revenue Growth Rate (2014-2024)
11 Global Rifaximin Market Segment by Application
11.1 Global Rifaximin Revenue Market Share by Application (2014-2019)
11.2 Rifaximin Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Drug store Revenue Growth (2014-2019)
12 Global Rifaximin Market Size Forecast (2019-2024)
12.1 Global Rifaximin Market Size Forecast (2019-2024)
12.2 Global Rifaximin Market Forecast by Regions (2019-2024)
12.3 North America Rifaximin Revenue Market Forecast (2019-2024)
12.4 Europe Rifaximin Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Rifaximin Revenue Market Forecast (2019-2024)
12.6 South America Rifaximin Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Rifaximin Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Rifaximin Picture
Table Product Specifications of Rifaximin
Table Global Rifaximin and Revenue (Million USD) Market Split by Product Type
Figure Global Rifaximin Revenue Market Share by Types in 2018
Figure 200 mg Tablets Picture
Figure 550 mg Tablets Picture
Table Global Rifaximin Revenue (Million USD) by Application (2015-2025)
Figure Rifaximin Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Drug store Picture
Table Global Market Rifaximin Revenue (Million USD) Comparison by Regions 2015-2025
Figure North America Rifaximin Revenue (Million USD) and Growth Rate (2015-2025)
Figure Europe Rifaximin Revenue (Million USD) and Growth Rate (2015-2025)
Figure Asia-Pacific Rifaximin Revenue (Million USD) and Growth Rate (2015-2025)
Figure South America Rifaximin Revenue (Million USD) and Growth Rate (2015-2025)
Figure Middle East and Africa Rifaximin Revenue (Million USD) and Growth Rate (2015-2025)
Figure Global Rifaximin Revenue (Million USD) and Growth Rate (2015-2025)
Table Salix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Salix Pharmaceuticals Rifaximin Type and Applications
Table Salix Pharmaceuticals Rifaximin Revenue, Gross Margin and Market Share (2017-2018)
Table Global Rifaximin Revenue (Million USD) by Players (2014-2019)
Table Global Rifaximin Revenue Share by Players (2014-2019)
Figure Global Rifaximin Revenue Share by Players in 2017
Figure Global Rifaximin Revenue Share by Players in 2018
Figure Global Top 5 Players Rifaximin Revenue Market Share in 2018
Figure Global Top 10 Players Rifaximin Revenue Market Share in 2018
Figure Global Rifaximin Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Rifaximin Revenue (Million USD) by Regions (2014-2019)
Table Global Rifaximin Revenue Market Share by Regions (2014-2019)
Figure Global Rifaximin Revenue Market Share by Regions (2014-2019)
Figure Global Rifaximin Revenue Market Share by Regions in 2018
Figure North America Rifaximin Revenue and Growth Rate (2014-2019)
Figure Europe Rifaximin Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Rifaximin Revenue and Growth Rate (2014-2019)
Figure South America Rifaximin Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Rifaximin Revenue and Growth Rate (2014-2019)
Table North America Rifaximin Revenue by Countries (2014-2019)
Table North America Rifaximin Revenue Market Share by Countries (2014-2019)
Figure North America Rifaximin Revenue Market Share by Countries (2014-2019)
Figure North America Rifaximin Revenue Market Share by Countries in 2018
Figure USA Rifaximin Revenue and Growth Rate (2014-2019)
Figure Canada Rifaximin Revenue and Growth Rate (2014-2019)
Figure Mexico Rifaximin Revenue and Growth Rate (2014-2019)
Table Europe Rifaximin Revenue (Million USD) by Countries (2014-2019)
Figure Europe Rifaximin Revenue Market Share by Countries (2014-2019)
Figure Europe Rifaximin Revenue Market Share by Countries in 2018
Figure Germany Rifaximin Revenue and Growth Rate (2014-2019)
Figure UK Rifaximin Revenue and Growth Rate (2014-2019)
Figure France Rifaximin Revenue and Growth Rate (2014-2019)
Figure Russia Rifaximin Revenue and Growth Rate (2014-2019)
Figure Italy Rifaximin Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Rifaximin Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Rifaximin Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Rifaximin Revenue Market Share by Countries in 2018
Figure China Rifaximin Revenue and Growth Rate (2014-2019)
Figure Japan Rifaximin Revenue and Growth Rate (2014-2019)
Figure Korea Rifaximin Revenue and Growth Rate (2014-2019)
Figure India Rifaximin Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Rifaximin Revenue and Growth Rate (2014-2019)
Table South America Rifaximin Revenue by Countries (2014-2019)
Table South America Rifaximin Revenue Market Share by Countries (2014-2019)
Figure South America Rifaximin Revenue Market Share by Countries (2014-2019)
Figure South America Rifaximin Revenue Market Share by Countries in 2018
Figure Brazil Rifaximin Revenue and Growth Rate (2014-2019)
Figure Argentina Rifaximin Revenue and Growth Rate (2014-2019)
Figure Colombia Rifaximin Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Rifaximin Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Rifaximin Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Rifaximin Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Rifaximin Revenue Market Share by Countries in 2018
Figure Saudi Arabia Rifaximin Revenue and Growth Rate (2014-2019)
Figure UAE Rifaximin Revenue and Growth Rate (2014-2019)
Figure Egypt Rifaximin Revenue and Growth Rate (2014-2019)
Figure Nigeria Rifaximin Revenue and Growth Rate (2014-2019)
Figure South Africa Rifaximin Revenue and Growth Rate (2014-2019)
Table Global Rifaximin Revenue (Million USD) by Type (2014-2019)
Table Global Rifaximin Revenue Share by Type (2014-2019)
Figure Global Rifaximin Revenue Share by Type (2014-2019)
Figure Global Rifaximin Revenue Share by Type in 2019
Table Global Rifaximin Revenue Forecast by Type (2019-2024)
Figure Global Rifaximin Market Share Forecast by Type (2019-2024)
Figure Global 200 mg Tablets Revenue Growth Rate (2014-2019)
Figure Global 550 mg Tablets Revenue Growth Rate (2014-2019)
Table Global Rifaximin Revenue by Application (2014-2019)
Table Global Rifaximin Revenue Share by Application (2014-2019)
Figure Global Rifaximin Revenue Share by Application (2014-2019)
Figure Global Rifaximin Revenue Share by Application in 2019
Table Global Rifaximin Revenue Forecast by Application (2019-2024)
Figure Global Rifaximin Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Drug store Revenue Growth Rate (2014-2019)
Figure Global Rifaximin Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Rifaximin Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Rifaximin Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Rifaximin Revenue Market Forecast (2019-2024)
Figure Europe Rifaximin Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Rifaximin Revenue Market Forecast (2019-2024)
Figure South America Rifaximin Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Rifaximin Revenue Market Forecast (2019-2024)

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz